Hunt for thousands of women left at risk from "silent Thalidomide" after their mothers took anti-miscarriage drugs

'Silent Thalidomide': Thousands of mothers and their daughters at risk of cancer from anti-miscarriage drugs they took decades ago Recent study found drug doubled risk of breast cancer in DES daughters aged over 40 Around 2,000 women have brought cases against drug companies in America after DES exposure Thousands of women whose mothers were prescribed the common pregnancy drug DES are unaware they are at greater risk of a number of cancers, according to experts.